Canada NewsWire TORONTO, Jan. 11, 2019 TORONTO, Jan. 11, 2019 /CNW/ – FSD Pharma (“FSD“) announced today that, in connection with the business combination (the “Business Combination“) completed on December 31, 2018 among Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) (the “Issuer“), Cannara Biotech Inc. and 11038427 Canada Inc., FSD... Read more
Ryan Allway January 8th, 2019 Uncategorized The O’Cannabiz Conference and Expo in Vancouver, Canada last month featured hundreds of cannabis companies from around the world this year—and CFN Media was there to film exclusive interviews with many of the leaders in the space. Lexaria Biosciences Inc. (CSE: LXX) (OTCQX:... Read more
Biotechnology company Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) revolutionary technology, DehydraTECH, alters the way that fat soluble, plant-derived molecules are absorbed into the body. A recent article further discussing the company reads, “Chemicals or intimidating complex ingredients that require disclosure on food labels are not required additions when using... Read more
TORONTO, Dec. 28, 2018 CSE: HCOTC: HHPHFFSE: 0HCN TORONTO, Dec. 28, 2018 /CNW/ – High Hampton Holdings Corp. (CSE: HC) (FSE: 0HCN) (“High Hampton” or the “Company”) today announced that it has filed its Consolidated Audited Financial Statements for the year ended August 31, 2018. The Consolidated Financial Statements... Read more
Ryan Allway December 20th, 2018 Uncategorized Gabriella’s Kitchen (CSE: GABY) appears to be on the leading edge to service both mainstream grocery and cannabis distribution channels with CBD infused products, as well as CBD and THC-infused edible and wellness products throughout Canada and the U.S. Positioned to be... Read more
Ryan Allway December 20th, 2018 Uncategorized Canada’s cannabis industry may be rapidly growing with new initial public offerings each week, but there has also been a fair share of consolidation within the industry. Investors may want to take a closer look at industry mergers, since they have the... Read more
Ryan Allway December 20th, 2018 Uncategorized Cannabinoids have the potential to radically transform the pharmaceutical industry. For example, new studies suggest that cannabis legalization could reduce opioid prescriptions by about six to 12 percent. The problem is that medical cannabis is very different from pharmaceutical drugs—it’s hard for... Read more
Ryan Allway December 20th, 2018 – 2018 pipeline expansion includes lead cannabinoid-based cancer therapeutic– Clinical trial in glioblastoma to begin in 2019 VANCOUVER, British Columbia and SEATTLE, Dec. 20, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced... Read more
“While Mojave Jane’s production delivers revenue and cash flow to the Company, it also means realizing the advantages of integrating with High Hampton’s complete portfolio”, commented Gary Latham, High Hampton’s CEO. “That is where the real long term value of this company will be realized.” About Mojave Jane LLC.... Read more
Ryan Allway December 18th, 2018 Exclusive, News, Press Releases, Top News The music industry has become increasingly intertwined with the cannabis industry over the past several years. With the partnership between Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) and Snoop Dogg in 2016, these relationships grew even closer... Read more